<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drug\PMC7269953\results\search\testTrace\results.xml">
  <result pre=": Article Immune checkpoint inhibitors: a physiology-driven approach to the" exact="treatment" post="of coronavirus disease 2019 Di CosimoSerenaaMalfettoneAndreabPÃ©rez-GarcÃ­aJosÃ© M.bcLlombart-CussacAntoniobdMiceliRosalbaeCuriglianoGiuseppefgCortÃ©sJavierjacortes@vhio.netbchâˆ—[a], [b], [c],"/>
  <result pre="immune checkpoint inhibitors that have been recently tested beyond cancer" exact="treatment" post="for their potential to restore cellular immunocompetence. Highlights â€¢Patients"/>
  <result pre="Antiâ€&quot;IL-6R Pembrolizumab Tocilizumab Coronavirus disease 2019 (COVID-19) is a pandemic" exact="infection" post="caused by a positive-sense RNA betacoronavirus named severe acute"/>
  <result pre="[3]. Whether cancer per se increases the risk of SARS-CoV-2" exact="infection" post="and its complications or rather cancer-associated comorbidities and treatment"/>
  <result pre="SARS-CoV-2 infection and its complications or rather cancer-associated comorbidities and" exact="treatment" post="remains to be clarified. A recent study showed that"/>
  <result pre="of the patients in this study received anticancer immunotherapy including" exact="treatment" post="with immune checkpoint inhibitors (ICIs), which are extensively used"/>
  <result pre="Among immune-activating drugs, ICIs have been recently tested beyond cancer" exact="treatment" post="for their potential to restore immunocompetence in the context"/>
  <result pre="in patients with sepsis-induced immunosuppression [12]. Another intervention aimed at" exact="testing" post="the safety of ICIs was influenza vaccination in patients"/>
  <result pre="worsening immune-related adverse events after the first 6 months of" exact="treatment" post="[15]. These data suggest that ICIs enhance T-cell response"/>
  <result pre="to better outline the value of immune-modulating agents in the" exact="treatment" post="of COVID-19. Current evidence revealed that a timely anti-inflammation"/>
  <result pre="treatment of COVID-19. Current evidence revealed that a timely anti-inflammation" exact="treatment" post="is of pivotal importance in avoiding exacerbation and preventing"/>
  <result pre="an uncontrolled inflammatory cascade [17]. Therefore, the use of antiâ€&quot;PD-1" exact="treatment" post="would produce satisfactory therapeutic effects in combination with an"/>
  <result pre="survival than homozygosity for one or more HLA-I genes, and" exact="treatment" post="efficacy was diminished by loss of HLA-I heterozygosity [20]."/>
  <result pre="a retrospective cohort studyLancet3951022920201054106210.1016/S0140-6736(20)30566-332171076 3WangT.DuZ.ZhuF.CaoZ.AnY.GaoY.Comorbidities and multi-organ injuries in the" exact="treatment" post="of COVID-19Lancet395102282020e5210.1016/S0140-6736(20)30558-432171074 4LiangW.GuanW.ChenR.WangW.LiJ.XuK.Cancer patients in SARS-CoV-2 infection: a nationwide"/>
  <result pre="Wuhan, ChinaJAMA Oncol202010.1001/jamaoncol.2020.0980Published online March 25 6BersanelliM.ScalaS.AffanniP.VeronesiL.ColucciM.E.BannaG.L.Immunological insights on influenza" exact="infection" post="and vaccination during immune checkpoint blockade in cancer patientsImmunotherapy122202010511010.2217/imt-2019-020032046555"/>
  <result pre="novel coronavirus pneumonia in Wuhan, China: a descriptive studyLancet39510223202050751310.1016/S0140-6736(20)30211-732007143 16XuX.HanM.LiT.SunW.WangD.FuB.Effective" exact="treatment" post="of severe COVID-19 patients with tocilizumabChina1172020109701097510.1073/pnas.2005615117 17AhnE.ArakiK.HashimotoM.LiW.RileyJ.L.CheungJ.Role of PD-1"/>
 </snippets>
</snippetsTree>
